Valeo Pharma Inc. announced that Mr. Frederic Fasano has stepped down as Valeo's President and Chief Operating Officer. Mr. Fasano will continue to act as special advisor to the Company and will remain on the Board of Directors. Mr. Fasano's duties and responsibilities are being integrated and assumed by the Company's CEO, Steve Saviuk and its Chief Commercial Officer, Mr. Kyle Steiger.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.095 CAD | +5.56% | 0.00% | -47.22% |
04-25 | Transcript : Valeo Pharma Inc. - Shareholder/Analyst Call | |
03-22 | Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.22% | 6.87M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+14.04% | 238B | |
+6.83% | 204B | |
-6.54% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- VPH Stock
- News Valeo Pharma Inc.
- Valeo Pharma Inc. Announces Stepping Down of Frederic Fasano as President and Chief Operating Officer